Cinanserin

Last updated
Cinanserin
Cinanserine.svg
Clinical data
ATC code
  • none
Identifiers
  • (2E)-N-(2-{[3-(dimethylamino)propyl]thio}phenyl)-3-phenylacrylamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.220.552 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C20H24N2OS
Molar mass 340.49 g·mol−1
3D model (JSmol)
  • CN(C)CCCSC1=CC=CC=C1NC(=O)\C=C\C2=CC=CC=C2
  • InChI=1S/C20H24N2OS/c1-22(2)15-8-16-24-19-12-7-6-11-18(19)21-20(23)14-13-17-9-4-3-5-10-17/h3-7,9-14H,8,15-16H2,1-2H3,(H,21,23)/b14-13+ X mark.svgN
  • Key:RSUVYMGADVXGOU-BUHFOSPRSA-N X mark.svgN
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Cinanserin (INN) is a 5-HT2A/5-HT2C receptor antagonist discovered in the 1960s. [1] [2] It has about 50-fold higher affinity for the 5-HT2A receptor than for 5-HT2C, and very low affinity for 5-HT1 receptors. [2]

Cinanserin also inhibits the 3C-like protease of SARS-CoV-1 [3] and SARS-CoV-2, [4] but with much lower affinity.

See also

References

  1. Neuman RS, Zebrowska G (December 1992). "Serotonin (5-HT2) receptor mediated enhancement of cortical unit activity". Canadian Journal of Physiology and Pharmacology. 70 (12): 1604–9. doi:10.1139/y92-230. PMID   1301238.
  2. 1 2 Glennon RA (January 1987). "Central serotonin receptors as targets for drug research". J Med Chem. 30 (1): 1–12. doi:10.1021/jm00384a001. PMID   3543362. Table II. Affinities of Selected Phenalkylamines for 5-HT1 and 5-HT2 Binding Sites
  3. Chen L, Gui C, Luo X, Yang Q, Günther S, Scandella E, et al. (June 2005). "Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro". Journal of Virology. 79 (11): 7095–103. doi:10.1128/JVI.79.11.7095-7103.2005. PMC   1112131 . PMID   15890949.
  4. Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C, Duan Y, Yu J, Wang L, Yang K, Liu F, Jiang R, Yang X, You T, Liu X, Yang X, Bai F, Liu H, Liu X, Guddat LW, Xu W, Xiao G, Qin C, Shi Z, Jiang H, Rao Z, Yang H (June 2020). "Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors". Nature. 582 (7811): 289–293. doi: 10.1038/s41586-020-2223-y . PMID   32272481. Cinanserin is an inhibitor of SARS-CoV-2 Mpro.